Leptin, obesity, and obstructive sleep apnea

Chest

Volumn 118, Issue 3, 2000, Pages 569-571

  Marik, P E ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; NEUROPEPTIDE Y;

ANIMAL MODEL; BODY MASS; DISEASE ASSOCIATION; EDITORIAL; FORCED EXPIRATORY VOLUME; HORMONE RESISTANCE; LUNG FUNCTION TEST; LUNG MINUTE VOLUME; MOUSE; NONHUMAN; OBESITY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RESPIRATION DEPRESSION; SLEEP APNEA SYNDROME; TOTAL LUNG CAPACITY; VITAL CAPACITY; WEIGHT REDUCTION;

EID: 0033806384     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.118.3.569     Document Type: Editorial

References (27)

1. Varying body mass index cutoff points to describe overweight prevalence among U.S. adults: NHANES III (1988 to 1994)
2. Increasing prevalence of overweight among US adults: The National Health and Nutrition Examination Surveys, 1960-1991
3. Overweight and obesity in the United States: Prevalence and trends, 1960-1994
4. Body-mass index and mortality in a prospective cohort of U.S. adults
5. Distribution of adipose tissue and risk of cardiovascular disease and death: A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden
6. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913
7. Effects of obesity on respiratory function
8. Effects of obesity and fat distribution on ventilatory function: The normative aging study
9. The effect of body fat distribution on pulmonary function tests
10. Total respiratory system, lung, and chest wall mechanics in sedated-paralyzed postoperative morbidly obese patients
11. Compliance of the chest wall in obese subjects
12. Regional distribution of pulmonary ventilation and perfusion in obesity
13. A prospective study of risk factors for pulmonary embolism in women
14. The occurrence of sleep-disordered breathing among middle-aged adults
15. Sleep apnea and sleep disruption in obese patients
16. Positional cloning of the mouse obese gene and its human homologue
17. Leptin: Its role in obesity and beyond
18. The role of leptin in human obesity and disease: A review of current evidence
19. The role of neuropeptide Y in the antiobesity action of the obese gene product
20. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y
21. Direct antidiabetic effect of leptin through triglyceride depletion of tissues
22. Leptin, leptin receptors, and the control of body weight
23. Leptin selectively decreases visceral adiposity and enhances insulin action
24. Recombinant leptin for weight loss in obese and lean adults: A randomized, controlled, dose-escalation trial
25. Leptin attenuates respiratory complications associated with the obese phenotype
26. Leptin prevents respiratory depression in obesity
27. Changes in intraabdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy